Irwin Neisler, & Company Report issue

Contributed to NME For profit
Founded: Decatur IL United States (1886)
Status: Defunct (1995)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1950
veratrum viride root (vertavis)
First NDA Approval
1950
veratrum viride root (vertavis)
Last Known Activity
1959

Timeline

NOW
  • Now

Active Ingredients

Marketed Drugs (3)

hexafluorenium (mylaxen) (1959 NDA)

veratrine (Unitensin) (1953 NDA)

veratrum viride root (vertavis) (1950 NDA)

Indications

Approved Indications


 

Muscle Contraction

Overview

  • Highest Phase: None
  • # of Trials: 0
  • # of Trial APIs: 0